enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Disease-modifying antirheumatic drug - Wikipedia

   en.wikipedia.org/wiki/Disease-modifying_anti...

   DMARDs help control arthritis, but do not cure the disease. For that reason, if remission or optimal control is achieved with a DMARD, it is often continued as a maintenance dosage. Discontinuing a DMARD may reactivate disease or cause a "rebound flare", with no assurance that disease control will be re-established upon resumption of the ...

3. Rheumatoid arthritis - Wikipedia

   en.wikipedia.org/wiki/Rheumatoid_arthritis

   Other: Other tools to monitor remission in rheumatoid arthritis are: ACR-EULAR Provisional Definition of Remission of Rheumatoid arthritis, Simplified Disease Activity Index and Clinical Disease Activity Index. [100] Some scores do not require input from a healthcare professional and allow self-monitoring by the person, like HAQ-DI.

4. Antiarthritics - Wikipedia

   en.wikipedia.org/wiki/Antiarthritics

   Ultimately, antiarthritic treatments aim to achieve disease remission or low disease activity if remission cannot be achieved and thereby improving quality of life. [ 8 ] The pharmacological effects of antiarthritic medications are typically exerted through the reduction of inflammation, suppression of the immune system and/or aid in easing pain.

5. Rheumatoid arthritis linked to changes in the gut microbiome ...

   www.aol.com/rheumatoid-arthritis-linked-changes...

   As of 2020, about 17.6 million people globally were living with rheumatoid arthritis, an autoimmune disease causing painful inflammation and swelling in joints. Scientists are still not sure as to ...

6. List of therapeutic monoclonal antibodies - Wikipedia

   en.wikipedia.org/wiki/List_of_therapeutic...

   rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis, Crohn's disease, ulcerative colitis Intetumumab [82] [83] mab: human: CD51: solid tumors (prostate cancer, melanoma) Inolimomab: mab: mouse: CD25 (α chain of IL-2 receptor) graft versus host disease Inotuzumab ozogamicin [39] Besponsa: mab: humanized: CD22: Y: Acute ...

7. Remitting seronegative symmetrical synovitis with pitting edema

   en.wikipedia.org/wiki/Remitting_seronegative...

   Other rheumatological disorders that can cause the features typical for RS3PE include late onset (seronegative) rheumatoid arthritis, acute sarcoidosis, ankylosing spondylitis and other spondyloarthropathies such as psoriatic arthropathy, mixed connective tissue disease, chondrocalcinosis and arthropathy due to amyloidosis. [6] [9]